Management of bioequivalence test to be strengthened

Published: 2002-03-14 06:59:00

Updated: 2002-03-14 06:59:00

The Korea Food and Administration has announced that if a person intends to obtain a new license on those items which were already approved before 1989, he/she will be subject to the bioequivalence test instead of fulfilling the safety and efficacy test of drugs in the past, since the bioequivale...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK